These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12030342)

  • 1. Opening of K(ATP) channel attenuates the increase in QT dispersion produced by the first balloon inflation during coronary angioplasty.
    Ashikaga T; Nishizaki M; Arita M; Yamawake N; Fujii H; Kishi Y; Isobe M; Hiraoka M
    Circ J; 2002 May; 66(5):469-72. PubMed ID: 12030342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty.
    Kato T; Kamiyama T; Maruyama Y; Tanaka S; Yoshimoto N
    Am Heart J; 2001 Jun; 141(6):940-3. PubMed ID: 11376307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicorandil can reduce QT dispersion and prevent bradyarrhythmia during percutaneous transluminal coronary angioplasty of the right coronary artery.
    Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):179-84. PubMed ID: 15378138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction.
    Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
    Can J Cardiol; 2004 May; 20(6):625-9. PubMed ID: 15152293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
    Patel DJ; Purcell HJ; Fox KM
    Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
    Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M
    J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias with left bundle branch block pattern and inferior axis: assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil.
    Kobayashi Y; Yazawa T; Adachi T; Kawamura M; Ryu S; Asano T; Obara C; Katagiri T
    Jpn Circ J; 2000 Nov; 64(11):835-41. PubMed ID: 11110427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in ventricular repolarization during percutaneous transluminal coronary angioplasty in humans assessed by QT interval, QT dispersion and T vector loop morphology.
    Nowinski K; Jensen S; Lundahl G; Bergfeldt L
    J Intern Med; 2000 Aug; 248(2):126-36. PubMed ID: 10947891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty.
    Yasuda T; Hashimura K; Matsu-ura Y; Kato Y; Ueda T; Mori I; Kijima Y
    Jpn Circ J; 2001 Jun; 65(6):526-30. PubMed ID: 11407735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of balloon inflation-induced acute ischemia on QT dispersion during percutaneous transluminal coronary angioplasty.
    Aytemir K; Bavafa V; Ozer N; Aksoyek S; Oto A; Ozmen F
    Clin Cardiol; 1999 Jan; 22(1):21-4. PubMed ID: 9929750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty.
    Okishige K; Yamashita K; Yoshinaga H; Azegami K; Satoh T; Goseki Y; Fujii S; Ohira H; Satake S
    J Am Coll Cardiol; 1996 Jul; 28(1):70-3. PubMed ID: 8752796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.
    Matsubara T; Minatoguchi S; Matsuo H; Hayakawa K; Segawa T; Matsuno Y; Watanabe S; Arai M; Uno Y; Kawasaki M; Noda T; Takemura G; Nishigaki K; Fujiwara H
    J Am Coll Cardiol; 2000 Feb; 35(2):345-51. PubMed ID: 10676679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.
    Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
    Circ J; 2002 Apr; 66(4):317-22. PubMed ID: 11954943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of QT-interval variability to ventricular arrhythmias during percutaneous transluminal coronary angioplasty.
    Kajiyama A; Saito D; Murakami T; Shiraki T; Oka T; Doi M; Masaka T; Tanemoto K; Tsuji T
    Jpn Circ J; 2001 Sep; 65(9):779-82. PubMed ID: 11548875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction.
    Horinaka S; Kobayashi N; Yabe A; Asakawa H; Yagi H; Mori Y; Tsubokou Y; Yoshida K; Nakano S; Matsuoka H
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):13-22. PubMed ID: 15115899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil infusion leads to good recovery from ischemia of left ventricular regional work in comparison with nitroglycerin.
    Isobe N; Oshima S; Taniguchi K; Hoshizaki H; Adachi H; Toyama T; Naito S; Nogami A; Sugawara M
    Circ J; 2002 Oct; 66(10):943-8. PubMed ID: 12381090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty.
    Lee TM; Su SF; Chou TF; Tsai CH
    J Am Coll Cardiol; 2002 Mar; 39(5):871-7. PubMed ID: 11869855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia.
    Kobayashi Y; Miyata A; Tanno K; Kikushima S; Baba T; Katagiri T
    J Am Coll Cardiol; 1998 Nov; 32(5):1377-83. PubMed ID: 9809951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiischemic effects of nicorandil during coronary angioplasty in humans.
    Saito S; Mizumura T; Takayama T; Honye J; Fukui T; Kamata T; Moriuchi M; Hibiya K; Tamura Y; Ozawa Y
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():257-63. PubMed ID: 7647030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction].
    Hara H; Horinaka S; Yabe A; Yagi H; Tsuboko Y; Yoshida K; Iemura T; Matsuoka H
    J Cardiol; 2007 Mar; 49(3):135-41. PubMed ID: 17444139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.